{"context":{"query":">>uniprot>>pdb","source_dataset":"uniprot","target_dataset":"pdb"},"stats":{"queried":1,"total":85,"mapped":1},"pagination":{"has_next":false},"schema":"id|title|method|resolution|source_organism|chain_count|header","mappings":[{"input":"P00519","source":"P00519|Tyrosine-protein kinase ABL1","targets":["1AB2|THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABL|SOLUTION NMR||Homo sapiens|0|TRANSFERASE(PHOSPHOTRANSFERASE)","1AWO|THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUCTURES|SOLUTION NMR||Homo sapiens|0|KINASE","1BBZ|CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMPLICATIONS FOR SH3-LIGAND INTERACTIONS|X-RAY DIFFRACTION|1.65|Homo sapiens|0|COMPLEX (TRANSFERASE/PEPTIDE)","1JU5|Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectroscopy|SOLUTION NMR||Homo sapiens; Mus musculus|0|PROTEIN BINDING/TRANSFERASE","1OPL|Structural basis for the auto-inhibition of c-Abl tyrosine kinase|X-RAY DIFFRACTION|3.42|Homo sapiens|0|TRANSFERASE","1ZZP|Solution structure of the F-actin binding domain of Bcr-Abl/c-Abl|SOLUTION NMR||Homo sapiens|0|TRANSFERASE","2ABL|SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASE|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE","2E2B|Crystal structure of the c-Abl kinase domain in complex with INNO-406|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","2F4J|Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinase Inhibitor VX-680|X-RAY DIFFRACTION|1.91|Homo sapiens|0|TRANSFERASE","2FO0|Organization of the SH3-SH2 Unit in Active and Inactive Forms of the c-Abl Tyrosine Kinase|X-RAY DIFFRACTION|2.27|Homo sapiens|0|TRANSFERASE","2G1T|A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain|X-RAY DIFFRACTION|1.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","2G2F|A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain|X-RAY DIFFRACTION|2.7|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","2G2H|A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain|X-RAY DIFFRACTION|2|Homo sapiens|0|TRANSFERASE","2G2I|A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain|X-RAY DIFFRACTION|3.12|Homo sapiens; SYNTHETIC CONSTRUCT|0|TRANSFERASE","2GQG|X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","2HIW|Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhibitor|X-RAY DIFFRACTION|2.2|Homo sapiens|0|TRANSFERASE","2HYY|Human Abl kinase domain in complex with imatinib (STI571, Glivec)|X-RAY DIFFRACTION|2.4|Homo sapiens|0|TRANSFERASE","2HZ0|Abl kinase domain in complex with NVP-AEG082|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE","2HZ4|Abl kinase domain unligated and in complex with tetrahydrostaurosporine|X-RAY DIFFRACTION|2.8|Homo sapiens|0|TRANSFERASE","2HZI|Abl kinase domain in complex with PD180970|X-RAY DIFFRACTION|1.7|Homo sapiens|0|TRANSFERASE","2O88|Crystal structure of the N114A mutant of ABL-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions|X-RAY DIFFRACTION|1.75|Homo sapiens; SYNTHETIC CONSTRUCT|0|SIGNALING PROTEIN","2V7A|Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358|X-RAY DIFFRACTION|2.5|HOMO SAPIENS|0|TRANSFERASE","3CS9|Human ABL kinase in complex with nilotinib|X-RAY DIFFRACTION|2.21|Homo sapiens|0|TRANSFERASE","3EG0|Crystal structure of the N114T mutant of ABL-SH3 domain|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","3EG1|Crystal structure of the N114Q mutant of ABL-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions|X-RAY DIFFRACTION|1.85|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/Signaling protein","3EG2|Crystal structure of the N114Q mutant of ABL-SH3 domain|X-RAY DIFFRACTION|1.8|Homo sapiens|0|TRANSFERASE","3EG3|Crystal structure of the N114A mutant of ABL-SH3 domain|X-RAY DIFFRACTION|1.4|Homo sapiens|0|TRANSFERASE","3EGU|Crystal structure of the N114A mutant of ABL-SH3 domain|X-RAY DIFFRACTION|2.25|Homo sapiens|0|TRANSFERASE","3K2M|Crystal Structure of Monobody HA4/Abl1 SH2 Domain Complex|X-RAY DIFFRACTION|1.75|Homo sapiens|0|SIGNALING PROTEIN/PROTEIN BINDING","3PYY|Discovery and Characterization of a Cell-Permeable, Small-molecule c-Abl Kinase Activator that Binds to the Myristoyl Binding Site|X-RAY DIFFRACTION|1.85|Homo sapiens|0|TRANSFERASE","3QRI|The crystal structure of human abl1 kinase domain in complex with DCC-2036|X-RAY DIFFRACTION|2.1|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3QRJ|The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036|X-RAY DIFFRACTION|1.82|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3QRK|The crystal structure of human abl1 kinase domain in complex with DP-987|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3T04|Crystal structure of monobody 7c12/abl1 sh2 domain complex|X-RAY DIFFRACTION|2.1|Homo sapiens|0|SIGNALING PROTEIN/PROTEIN BINDING","3UE4|Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the Abl tyrosine kinase domain|X-RAY DIFFRACTION|2.424|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","3UYO|Crystal structure of monobody SH13/ABL1 SH2 domain complex|X-RAY DIFFRACTION|1.83|Homo sapiens|0|SIGNALING PROTEIN/PROTEIN BINDING","4J9B|Crystal structure of the Abl-SH3 domain H59Q-N96T mutant|X-RAY DIFFRACTION|1.702|Homo sapiens|0|TRANSFERASE","4J9C|Crystal structure of the Abl-SH3 domain H59Q-N96T mutant complexed with the designed high-affinity peptide ligand P17|X-RAY DIFFRACTION|1.051|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/unknown function","4J9D|Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P0|X-RAY DIFFRACTION|1.5|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/unknown function","4J9E|Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptide P17|X-RAY DIFFRACTION|1.4|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/unknown function","4J9F|Crystal structure of the Abl-SH3 domain complexed with the high affinity peptide P0|X-RAY DIFFRACTION|1.094|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/unknown function","4J9G|Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 at pH7|X-RAY DIFFRACTION|1.8|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/unknown function","4J9H|Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7 at pH 8|X-RAY DIFFRACTION|1.7|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/unknown function","4J9I|Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P17|X-RAY DIFFRACTION|2.2|Homo sapiens; SYNTHETIC CONSTRUCT|0|Transferase/unknown function","4JJB|Crystal structure of the Abl-SH3 domain at pH3|X-RAY DIFFRACTION|1.65|Homo sapiens|0|TRANSFERASE","4JJC|Crystal structure of the Abl-SH3 domain at pH5|X-RAY DIFFRACTION|1.6|Homo sapiens|0|TRANSFERASE","4JJD|Crystal structure of the N114A Abl-SH3 domain mutant at pH4|X-RAY DIFFRACTION|1.6|Homo sapiens|0|TRANSFERASE","4TWP|The crystal structure of human abl1 T315I gatekeeper mutant kinase domain in complex with axitinib|X-RAY DIFFRACTION|2.4|Homo sapiens|0|Transferase/Transferase Inhibitor","4WA9|The crystal structure of human abl1 wild type kinase domain in complex with axitinib|X-RAY DIFFRACTION|2.2|Homo sapiens|0|Transferase/Transferase Inhibitor","4XEY|Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinase|X-RAY DIFFRACTION|2.891|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","4YC8|C-Helix-Out Binding of Dasatinib Analog to c-Abl Kinase|X-RAY DIFFRACTION|2.9|Homo sapiens|0|TRANSFERASE","4ZOG|VX-680/MK-0457 binds to human ABL1 also in inactive DFG conformations.|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","5DC0|CRYSTAL STRUCTURE OF MONOBODY GG3/ABL1 SH2 DOMAIN COMPLEX|X-RAY DIFFRACTION|2.23|Homo sapiens|0|PROTEIN BINDING","5DC4|CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX, CRYSTAL A|X-RAY DIFFRACTION|1.48|Homo sapiens|0|PROTEIN BINDING","5DC9|CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX, CRYSTAL B|X-RAY DIFFRACTION|1.56|Homo sapiens|0|PROTEIN BINDING","5HU9|Crystal structure of ABL1 in complex with CHMFL-074|X-RAY DIFFRACTION|1.529|Homo sapiens|0|TRANSFERASE/TRANSFERASE INHIBITOR","5MO4|ABL1 kinase (T334I_D382N) in complex with asciminib and nilotinib|X-RAY DIFFRACTION|2.17|Homo sapiens|0|TRANSFERASE","5NP2|Abl1 SH3 pTyr89/134|X-RAY DIFFRACTION|1.6|Homo sapiens|0|TRANSFERASE","5OAZ|Crystal structure of the Abl-SH3 domain at pH 7.5|X-RAY DIFFRACTION|1.03|Homo sapiens|0|TRANSFERASE","6AMV|Abl 1b Regulatory Module 'inhibiting state'|SOLUTION NMR||Homo sapiens|0|SIGNALING PROTEIN","6AMW|Abl1b Regulatory Module 'Activating' conformation|SOLUTION NMR||Homo sapiens|0|SIGNALING PROTEIN","6BL8|Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models|X-RAY DIFFRACTION|2.5|Homo sapiens|0|TRANSFERASE","6NPE|C-abl Kinase domain with the activator(cmpd6), 2-cyano-N-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetamide|X-RAY DIFFRACTION|2.15|Homo sapiens|0|TRANSFERASE","6NPU|C-abl Kinase domain with the activator(cmpd29), N-(1-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)acetamide|X-RAY DIFFRACTION|2.33|Homo sapiens|0|TRANSFERASE","6NPV|C-abl Kinase domain with the activator(cmpd51), N-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-dihydro-1H-pyrazol-3-yl)isonicotinamide|X-RAY DIFFRACTION|1.86|Homo sapiens|0|TRANSFERASE","6XR6|Abl 1b isoform active state|SOLUTION NMR||Homo sapiens|0|ONCOPROTEIN","6XR7|Abl isoform 1b inactive1 state|SOLUTION NMR||Homo sapiens|0|ONCOPROTEIN","6XRG|Abl 1b isoform inactive2 state|SOLUTION NMR||Homo sapiens|0|ONCOPROTEIN","7CC2|Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors|X-RAY DIFFRACTION|2.723|Homo sapiens|0|TRANSFERASE","7DT2|Strategic design of catalytic lysine-targeting reversible covalent BCR-ABL Inhibitors|X-RAY DIFFRACTION|2.3|Homo sapiens|0|TRANSFERASE","7N9G|Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib|X-RAY DIFFRACTION|2.2|Homo sapiens|0|CELL CYCLE","7PVQ|Crystal structure of the Abl SH3 domain V73E-A74S-S75R-G76T-D77E-G92N-Y93N-N94T-H95E mutant in the space group P21221|X-RAY DIFFRACTION|1.55|Homo sapiens|0|PROTEIN BINDING","7PVR|Crystal structure of the Abl SH3 domain V73E-A74S-S75R-G76T-D77E-G92N-Y93N-N94T-H95E mutant in the space group P41|X-RAY DIFFRACTION|1.65|Homo sapiens|0|PROTEIN BINDING","7PVS|Crystal structure of the Abl SH3 domain V73E-A74S-S75R-G76T-D77E-G92N-Y93N-N94T-H95E mutant in presence of PEG 200|X-RAY DIFFRACTION|1.05|Homo sapiens|0|PROTEIN BINDING","7PVV|Crystal structure of the Abl SH3 domain G92N-Y93N-N94T-H95E mutant|X-RAY DIFFRACTION|1.82|Homo sapiens|0|PROTEIN BINDING","7PW2|Crystal structure of the Abl SH3 domain V73E-A74S-S75R-G76T-D77E mutant|X-RAY DIFFRACTION|1.1|Homo sapiens|0|PROTEIN BINDING","7W7X|The crystal structure of human abl1 kinase domain in complex with ABL1-A11|X-RAY DIFFRACTION|2.00001|Homo sapiens|0|TRANSFERASE","7W7Y|The crystal structure of human abl1 kinase domain in complex with ABL2-A5|X-RAY DIFFRACTION|2.20003|Homo sapiens|0|TRANSFERASE","8H7F|The crystal structure of human abl1 kinase domain in complex with abl1-B-EBA|X-RAY DIFFRACTION|2.45013|Homo sapiens|0|TRANSFERASE","8H7H|The crystal structure of human abl1 kinase domain in complex with abl1-A-EBA|X-RAY DIFFRACTION|2.2779|Homo sapiens|0|TRANSFERASE","8I7S|The crystal structure of human abl1 kinase domain in complex with ABL1-B1|X-RAY DIFFRACTION|1.94635|Homo sapiens|0|TRANSFERASE","8I7T|The crystal structure of human abl1 kinase domain in complex with ABL1-B4|X-RAY DIFFRACTION|2.80005|Homo sapiens|0|TRANSFERASE","8I7Z|The crystal structure of human abl1 kinase domain in complex with ABL1-B5|X-RAY DIFFRACTION|2.25496|Homo sapiens|0|TRANSFERASE","8SSN|Abl kinase in complex with SKI and asciminib|X-RAY DIFFRACTION|2.86|Homo sapiens|0|TRANSFERASE","9KS5|The crystal structure of ABL1 in complex with K-CNBA-1|X-RAY DIFFRACTION|2.2|Homo sapiens|0|UNKNOWN FUNCTION"]}]}